Cargando…

CD300c is uniquely expressed on CD56(bright) Natural Killer Cells and differs from CD300a upon ligand recognition

Paired receptors on NK cells recognize similar ligands with varied strength of binding ability and perform different functions. The CD300 molecules are emerging as novel immune regulators in health and disease due to their interaction with their lipid-nature ligands. Particularly, the paired recepto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dimitrova, Milena, Zenarruzabeitia, Olatz, Borrego, Francisco, Simhadri, Venkateswara R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819222/ https://www.ncbi.nlm.nih.gov/pubmed/27040328 http://dx.doi.org/10.1038/srep23942

Ejemplares similares

The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults
por: Zenarruzabeitia, Olatz, et al.
Publicado: (2016)

Functional requirements for inhibitory signal transmission by the immunomodulatory receptor CD300a
por: DeBell, Karen E, et al.
Publicado: (2012)

Increased expression levels of CD300c on basophils from allergic individuals()
por: Vitallé, Joana, et al.
Publicado: (2019)

Differential expression of CD300a/c on human T(H)1 and T(H)17 cells
por: Simhadri, Venkateswara R, et al.
Publicado: (2011)

Polyfunctional HIV-1 specific response by CD8+ T lymphocytes expressing high levels of CD300a
por: Vitallé, Joana, et al.
Publicado: (2020)

The Expression and Function of CD300 Molecules in the Main Players of Allergic Responses: Mast Cells, Basophils and Eosinophils
por: Vitallé, Joana, et al.
Publicado: (2020)

CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients
por: Vitallé, Joana, et al.
Publicado: (2019)

Distinct Signatures in the Receptor Repertoire Discriminate CD56bright and CD56dim Natural Killer Cells
por: Schwane, Vera, et al.
Publicado: (2020)

Identification and Functional Analysis of Human CD56(neg) NK Cells by Flow Cytometry
por: Orrantia, Ane, et al.
Publicado: (2020)

Human Th1 Cells That Express CD300a Are Polyfunctional and After Stimulation Up-Regulate the T-Box Transcription Factor Eomesodermin
por: Narayanan, Sriram, et al.
Publicado: (2010)

CD56(bright) natural killer cells preferentially kill proliferating CD4(+) T cells
por: Lee, Mercede, et al.
Publicado: (2023)

Evaluation of CD56(dim) and CD56(bright) natural killer cells in peripheral blood of women with IVF failures
por: Mardanian, Farahnaz, et al.
Publicado: (2015)

Altered Expression of CD300a Inhibitory Receptor on CD4+ T Cells From Human Immunodeficiency Virus-1-Infected Patients: Association With Disease Progression Markers
por: Vitallé, Joana, et al.
Publicado: (2018)

A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) Cells
por: Simhadri, Venkateswara R., et al.
Publicado: (2015)

Human Natural Killer Cell Maturation Defect Supports In Vivo CD56(bright) to CD56(dim) Lineage Development
por: Domaica, Carolina Inés, et al.
Publicado: (2012)

The phenotype of CD3–CD56(bright) and CD3–CD56(dim) natural killer cells in systemic lupus erythematosus patients and its relation to disease activity
por: Soelistyoningsih, Dwi, et al.
Publicado: (2022)

Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations
por: Melsen, Janine E., et al.
Publicado: (2016)

T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19
por: Zenarruzabeitia, Olatz, et al.
Publicado: (2021)

Monocytes Phenotype and Cytokine Production in Human Immunodeficiency Virus-1 Infected Patients Receiving a Modified Vaccinia Ankara-Based HIV-1 Vaccine: Relationship to CD300 Molecules Expression
por: Vitallé, Joana, et al.
Publicado: (2017)

CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS
por: Elkins, J., et al.
Publicado: (2015)

Intratumoral CD56(bright) natural killer cells are associated with improved survival in bladder cancer
por: Mukherjee, Neelam, et al.
Publicado: (2018)

CD56(bright)CD16(-) natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease
por: Lauener, Madeline P., et al.
Publicado: (2022)

Effect of Specific Mutations in Cd300 Complexes Formation; Potential Implication of Cd300f in Multiple Sclerosis
por: Martínez-Barriocanal, Águeda, et al.
Publicado: (2017)

Hobit expression by a subset of human liver-resident CD56(bright) Natural Killer cells
por: Lunemann, Sebastian, et al.
Publicado: (2017)

CD56bright Natural Killer Cells: A Possible Biomarker of Different Treatments in Multiple Sclerosis
por: Laroni, Alice, et al.
Publicado: (2020)

CD56 Is a Pathogen Recognition Receptor on Human Natural Killer Cells
por: Ziegler, Sabrina, et al.
Publicado: (2017)

CD56(dim)CD16(high) and CD56(bright)CD16(−) cell percentages associated with maximum knee extensor strength and incidence of death in elderly
por: Senpuku, Hidenobu, et al.
Publicado: (2016)

Cytotoxicity of Human Hepatic Intrasinusoidal CD56(bright) Natural Killer Cells against Hepatocellular Carcinoma Cells
por: Hwang, Shin, et al.
Publicado: (2019)

Human IgM(hi)CD300a(+) B Cells Are Circulating Marginal Zone Memory B Cells That Respond to Pneumococcal Polysaccharides and Their Frequency Is Decreased in People Living with HIV
por: Vitallé, Joana, et al.
Publicado: (2023)

NK cells CD56(bright) and CD56(dim) subset cytokine loss and exhaustion is associated with impaired survival in myeloma
por: Seymour, Frances, et al.
Publicado: (2022)

The involvement of circulating CD69(+) CD56(bright) natural killer cells in weight loss before bariatric surgery: A retrospective cohort study
por: Chikuie, Emi, et al.
Publicado: (2023)

CD300LG improves the cytotoxic activity of CIK
por: Wang, Qiuyue, et al.
Publicado: (2017)

Human CD56(dim)CD16(dim) Cells As an Individualized Natural Killer Cell Subset
por: Amand, Mathieu, et al.
Publicado: (2017)

The Increased Ratio of Blood CD56(bright) NK to CD56(dim) NK Is a Distinguishing Feature of Primary Sjögren's Syndrome
por: Ming, Bingxia, et al.
Publicado: (2020)

ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56(dim)CD16(+) and CD56(bright)CD16(dim/−) natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
por: Huth, Teilah Kathryn, et al.
Publicado: (2016)

MicroRNA profiling of CD3(+)CD56(+) cytokine-induced killer cells
por: Wang, Wenju, et al.
Publicado: (2015)

Evidence for the involvement of CD56 molecules in alloantigen-specific recognition by human natural killer cells
Publicado: (1991)

Key Role of the CD56(low)CD16(low) Natural Killer Cell Subset in the Recognition and Killing of Multiple Myeloma Cells
por: Vulpis, Elisabetta, et al.
Publicado: (2018)

Impact of polysialylated CD56 on natural killer cell cytotoxicity
por: Moebius, Jeannette M, et al.
Publicado: (2007)

CD56(dim)CD16(dim) Natural Killer (NK) Cells: The Forgotten Population
por: Zimmer, Jacques
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jvr0vkgulgnf048qf3ggthas4k